These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27589568)

  • 1. T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.
    Beschel LM; Leu M; Reichardt SD; Rave-Fränk M; Schirmer MA; Stadelmann C; Canis M; Wolff HA; Reichardt HM
    Oncotarget; 2016 Oct; 7(40):65902-65915. PubMed ID: 27589568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
    Tehrany N; Kitz J; Rave-Fränk M; Lorenzen S; Li L; Küffer S; Hess CF; Burfeind P; Reichardt HM; Canis M; Beissbarth T; Wolff HA
    Strahlenther Onkol; 2015 Jul; 191(7):566-72. PubMed ID: 25575976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma.
    Martin D; Rödel F; von der Grün J; Rödel C; Fokas E
    Radiother Oncol; 2020 Aug; 149():168-173. PubMed ID: 32417344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.
    Schuler PJ; Harasymczuk M; Schilling B; Saze Z; Strauss L; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2013 Dec; 19(23):6585-96. PubMed ID: 24097865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
    Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
    Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistently elevated soluble MHC class I polypeptide-related sequence A and transforming growth factor-β1 levels are poor prognostic factors in head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Chen JL; Chang CC; Huang YS; Kuo HY; Chen TY; Wang CW; Kuo SH; Lin YL
    PLoS One; 2018; 13(8):e0202224. PubMed ID: 30096190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma.
    Krupar R; Hautmann MG; Pathak RR; Varier I; McLaren C; Gaag D; Hellerbrand C; Evert M; Laban S; Idel C; Sandulache V; Perner S; Bosserhoff AK; Sikora AG
    Am J Pathol; 2018 Jan; 188(1):72-83. PubMed ID: 29107073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyfunctionality of CD4
    Doescher J; Jeske S; Weissinger SE; Brunner C; Laban S; Bölke E; Hoffmann TK; Whiteside TL; Schuler PJ
    Strahlenther Onkol; 2018 May; 194(5):392-402. PubMed ID: 29663037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma.
    Rodrigues-Junior DM; Tan SS; de Souza Viana L; Carvalho AL; Lim SK; Iyer NG; Vettore AL
    BMC Cancer; 2019 Apr; 19(1):373. PubMed ID: 31014274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer.
    Pandit R; Lathers DM; Beal NM; Garrity T; Young MR
    Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):749-54. PubMed ID: 10961808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
    Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.
    Pavón MA; Parreño M; León X; Sancho FJ; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Int J Cancer; 2008 Sep; 123(5):1068-79. PubMed ID: 18546291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
    Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
    Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
    Shinoto M; Shioyama Y; Sasaki T; Nakamura K; Ohura H; Toh Y; Higaki Y; Yamaguchi T; Ohnishi K; Atsumi K; Hirata H; Honda H
    Am J Clin Oncol; 2011 Aug; 34(4):362-6. PubMed ID: 20686402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer.
    Cirauqui B; Margelí M; Quiroga V; Quer A; Karachaliou N; Chaib I; Ramírez JL; Muñoz A; Pollán C; Planas I; Drozdowsky A; Rosell R
    Tumour Biol; 2016 Oct; 37(10):13435-13443. PubMed ID: 27465548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
    Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
    Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Olofsson J
    Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.